Cell Culture Reagent Market Size, Share & Industry Analysis, By Product (Albumin, Amino Acids, Attachment Factors, Growth Factors and Cytokines, Hormones, Others), By Application (Biopharmaceutical Manufacturing, Tissue Culture and Engineering, Gene Therapy, Cytogenetics, Others), End User (Pharmaceutical and Biotechnology Companies , Academic Institutions and Laboratories, Others) And Regional Forecast, 2024-2032

Cell culture techniques require high purity reagents. These products offerings may also undergo further testing for pyrogens and endotoxins. Cell culture reagents may also contain sterile reagents, media supplements, and cell culture media. Some of the most common cell culture reagents includes amino acid and supplements and antibiotics.

Increasing investments in cell based research initiatives and rise in preference for customized medicines are few of the reasons for the growth of this market. Furthermore, rise in the demand for 3D cell culture and increase in the risk of communicable disease will generate great opportunities for the cell culture reagent market.

However high research and development (R&D) costs, and the unavailability of proper facilities and infrastructure for cell based research are few of the reasons which is limiting the market growth.

Market Segmentation:

Globally, the cell culture reagent market can be segmented on the basis of product, application, end user and region. Based on product, the market can be segmented into albumin, amino acids, attachment factors, growth hormones and cytokines, hormones and others. Based on application, the market can be segmented into biopharmaceutical manufacturing, tissue culture and engineering, gene therapy, cytogenetics and others. Based on end user, the market can be segment into pharmaceutical and biotechnology companies, academic institutions and laboratories and others. Geographically, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

Key Players Covered:

The major companies in the global cell culture reagent market report includes Becton, Dickinson and Company, CellGenix GmbH, Corning Incorporated, Merck KGaA, Bio-Rad Laboratories, Inc., FUJIFILM Irvine Scientific, Lonza, InvivoGen, PromoCell GmbH and other prominent players.

Key Insights

• New Product Launches


• Overview of R&D Advances in Cell Culture Reagents


• Impact of COVID-19 on the Global Cell Culture Reagent Market


• Key Industry Developments

Regional Analysis:

North America is the most dominant region in the global cell culture reagent market in terms of revenue, this is because the region has the most developed healthcare infrastructure and is engaged in various R&D initiatives. This region is most technically advanced compared to other regions. The North America region is also dominant in diseases such as neonatal jaundice, and skin diseases and possesses a very favourable reimbursement structure.

Europe is the second largest region is terms of revenue share of the global market. Increasing initiatives in drug discovery coupled with the strong focus on the development of the biotechnology industry in this region is expected to drive the market growth. Europe is followed by Asia Pacific, Latin America and the Middle East and Africa.

The Asia Pacific market is expected to witness the highest CAGR in terms of all the regions. The growth of this market is expected due to the increase in demand for biopharmaceuticals and ongoing stem cell research programs in this region. Latin America and the Middle East and Africa region are still lesser developed regions in comparison to other high growth regions, and is expected to have growth potential in the near future.

Segmentation

Cell Culture Reagent Market Industry Developments

• In July 2021, Sartorius announced that they have acquired major shares of CellGenix GmbH, a reagent manufacturing company. This acquisition helps Sartorius expand their cell and gene therapies product portfolio


• September 2020, FUJIFILM Irvine Scientific, Inc. announced that they have become the exclusive distributor for Cellnest, a recombinant peptide attachment substrate. This reagent was developed by FUJIFILM Corporation which expanded their existing portfolio for solutions which support life science innovations.